Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Cefoperazone (500mg) + Sulbactam (500mg)
Therapeutic Category
Antibacterials, Antibiotic, General and OTC medicines
Dosage Form
Injection
Packaging Type
vial
Packaging
1gm
Price
₹215/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Zepazon S 1 Gm Injection is a combination antibiotic formulation containing Cefoperazone (500mg) and Sulbactam (500mg), designed to treat a variety of bacterial infections. Cefoperazone is a third-generation cephalosporin antibiotic that works by inhibiting the synthesis of bacterial cell walls, leading to the death of susceptible bacteria. Sulbactam, a beta-lactamase inhibitor, enhances the activity of Cefoperazone by preventing bacterial enzymes (beta-lactamases) from inactivating the antibiotic, thus broadening its spectrum of activity.
This combination is highly effective in treating serious infections caused by both Gram-positive and Gram-negative bacteria, including sepsis, pneumonia, urinary tract infections (UTIs), skin and soft tissue infections, and intra-abdominal infections. The broad-spectrum nature of Cefoperazone-Sulbactam makes it suitable for use in hospital settings, particularly in patients who require intravenous therapy for severe or resistant infections.
Common side effects include allergic reactions, nausea, diarrhea, and changes in liver function tests. Serious side effects such as anaphylaxis or blood dyscrasias are rare but possible.
Treatment of serious infections like pneumonia, urinary tract infections (UTIs), skin and soft tissue infections, intra-abdominal infections, and sepsis.
Not recommended for patients with a known allergy to penicillin or cephalosporins. Use with caution in patients with kidney or liver impairment.
Store in a cool, dry place, away from direct sunlight. Keep out of the reach of children.
Composition : Azithromycin (500mg) Injection
Composition : Cefepime (1000mg) Injection
Composition : Cefepime (1000mg) + Tazobactum (125mg)
Composition : Cefepime (250mg)
Composition : Cefoperazone (1000mg) + Sulbactam (500mg)
Composition : Cefoperazone (2gm) + Sulbactam (1gm)
Composition : Ceftazidime (1gm)
Composition : Ceftazidime (250mg)
Composition : Ceftazidime (250mg) + Sulbactam (125mg)
Composition : Ceftriaxone (1000mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Cefoperazone 500mg + Sulbactam 500mg Injection has strong demand in the hospital and critical care antibiotic segment, making it a profitable product for medical distributors, wholesalers, and pharma franchise partners looking to expand in the PCD pharma franchise market.
Medical distributors and wholesalers can benefit from the consistent demand for this formulation in respiratory tract infections, urinary tract infections, abdominal infections, skin infections, and post-operative bacterial infections. It strengthens their injectable antibiotic portfolio.
Yes, Cafoli Lifecare offers PCD pharma franchise opportunities for Cefoperazone 500mg + Sulbactam 500mg Injection with monopoly rights, promotional support, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from strong hospital demand, attractive institutional sales opportunities, good margins, timely availability, and professional marketing support when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this critical care injection can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, bulk procurement, pricing details, and distribution support services.